1. PD-0081 SBRT, Durvalumab+-Tremelimumab in metastatic SCC: preliminary safety results of a phase I/II trial. (May 2022) Authors: Levy, A.; Bahleda, R.; Brard, C.; Durand-Labrunie, J.; Hollebecque, A.; Deutsch, E. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-0425: Radiomics for selection of patients treated with immuno-radiotherapy: pooled analysis from 6 studies. (November 2020) Authors: Sun, R.; Sundahl, N.; Hecht, M.; Putz, F.; Lancia, A.; Milic, M.; Carré, A.; Lerousseau, M.; Theo, E.; Battistella, E.; Andres, E. Alvarez; Louvel, G.; Durand-Labrunie, J.; Bockel, S.; Bahleda, R.; Robert, C.; Boutros, C.; Vakalopoulou, M.; Paragios, N.; Frey, B. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases. (November 2020) Authors: De Baère, T.; Pracht, M.; Rolland, Y.; Durand-Labrunie, J.; Nguyen, F.; Bronowicki, J.; Vendrely, V.; Cunha, A. Sa; Croisé-Laurent, V.; Rio, E.; Le Sourd, S.; Said, P.; Gustin, P.; Perret, C.; Peiffert, D.; Deutsch, E.; Chajon, E. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1105: Interstitial PDR brachytherapy for the treatment of squamous cell anal carcinoma. (November 2020) Authors: Bourdais, R.; Achkar, S.; Kumar, T.; Kissel, M.; Ta, M.H.; Pounou Kamga, F.A.; Boukhelif, W.; Durand-Labrunie, J.; Haie-Meder, C.; Chargari, C. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-1292 Stereotactic radiotherapy after chemotherapy in patients with locally advanced pancreatic cancer. (May 2022) Authors: Le Roy, C.; Barbe, R.; Sun, R.; Burtin, P.; Gelli, M.; Deutsch, E.; Durand-Labrunie, J. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PV-0105: Stereotactic body radiotherapy treatment for hepatocellular carcinoma: A phase II study. (April 2018) Authors: Durand-Labrunie, J.; Jarraya, H.; Boleslawski, E.; Cattan, S.; Lacornerie, T.; Peiffert, D.; Mirabel, X. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗